Medical Health Cluster

COVID-19

Remdesivir, Camostat Fail to Deliver in COVID-19 RCTs

 Two drugs that looked like promising treatments for COVID-19 in preliminary studies – remdesivir for hospitalized patients and camostat for patients who are not seriously ill – failed to show a benefit in those groups in randomized controlled trials, researchers reported in two separate papers. In five European countries, researchers […]

Read More

COVID Cases Rising in About Half of States

Though overall COVID-19 case counts continue to drop nationally, that’s not the story in every U.S. state. About half the states have reported increases in COVID cases fueled by the Omicron subvariant, Axios reported. Alaska, Vermont, and Rhode Island had the highest increases, with more than 20 new cases per 100,000 […]

Read More

Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021

Antibiotics are ineffective treatment for viral syndromes, including COVID-19. We characterized antibiotic prescribing in older adults with outpatient COVID-19 visits to identify opportunities to improve prescribing practices. Methods We used 100% Medicare carrier claims and Part D event files to identify beneficiaries with a COVID-19 outpatient visit and associated antibiotic […]

Read More

U.S. pulls COVID drug as Omicron subvariant spreads

Federal regulators have announced that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the United States, The Associated Press reports. The Food and Drug Administration announced that the antibody drug sotrovimab is no longer authorized to […]

Read More

Long-Term Cardiovascular Disease Following COVID-19

Risks for chronic disease rose among COVID-19 survivors, compared with risks among contemporary controls. COVID-19 often causes acute cardiovascular complications, even in young adults. To assess risk for chronic complications, investigators used U.S. Veterans Affairs (VA) databases to estimate new cardiovascular disease that was first diagnosed at least 30 days after initial positive COVID-19 […]

Read More

Los anticuerpos contra el Covid desaparecen a los 7 meses de pasarlo en casi la mitad de infectados

Ha quedado demostrado que tras pasar la enfermedad del Covid-19, se forman anticuerpos que protegen de la enfermedad. Sin embargo, estos anticuerpos tienen un tiempo establecido de duracion. Los anticuerpos contra el Covid-19 se vuelven indetectables en las pruebas serológicas en un 43,3% de los pacientes transcurridos siete meses desde la infección, según […]

Read More

Number of COVID Patients in US Hospitals Reaches Record Low

NORFOLK, Va. (AP) — COVID-19 hospitalization numbers have plunged to their lowest levels since the early days of the pandemic, offering a much needed break to health care workers and patients alike following the omicron surge. The number of patients hospitalized with the coronavirus has fallen more than 90% in […]

Read More

Más riesgo de infección y de muerte por COVID-19 en personas con trastorno por consumo de sustancias, aun estando vacunadas

MADRID, ESP. Las personas con un trastorno por consumo de sustancias presentan un riesgo más elevado de infectarse y de fallecer a causa de la COVID-19 que la población general, incluso habiendo recibido la pauta vacunal completa. Así lo ha demostrado una línea de investigación liderada por la psiquiatra mexicana […]

Read More